Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypotonia as Predictor of OPG in NF1
NCT02584413Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2013
- Primary completion
- Feb 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Washington University School of Medicine. Primary endpoint: Predictive accuracy of clinical diagnosis of hypotonia as an indicator of OPG in children with NF1 at 1 day. Started Apr 2013; status: terminated.
Beyond the preview
Go deeper on NCT02584413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584413.